---
title: "Key facts: Novo Nordisk Q1 sales down; Wegovy 50+ countries, Amazon"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/285650743.md"
description: "Novo Nordisk Q1 sales DKK70.1bn (-10% YoY); adjusted operating profit down 15%. Obesity drug Wegovy sales rose; Ozempic sales hit two-year low amid competition including Eli Lilly’s Foundayo.1Novo Nordisk rolls out Wegovy in 50+ countries as supply improves, expanding global availability to meet demand; rivals like Eli Lilly are also pursuing international launches.2Novo Nordisk (NOVO_B) GLP‑1 Wegovy now available via Amazon One Medical. Pricing: $25/month with insurance, $149/month cash. Offered through One Medical primary care for eligible patients.3"
datetime: "2026-05-08T02:05:36.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/285650743.md)
  - [en](https://longbridge.com/en/news/285650743.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/285650743.md)
---

# Key facts: Novo Nordisk Q1 sales down; Wegovy 50+ countries, Amazon

-   Novo Nordisk Q1 sales DKK70.1bn (-10% YoY); adjusted operating profit down 15%. Obesity drug Wegovy sales rose; Ozempic sales hit two-year low amid competition including Eli Lilly’s Foundayo.1
-   Novo Nordisk rolls out Wegovy in 50+ countries as supply improves, expanding global availability to meet demand; rivals like Eli Lilly are also pursuing international launches.2
-   Novo Nordisk (NOVO\_B) GLP‑1 Wegovy now available via Amazon One Medical. Pricing: $25/month with insurance, $149/month cash. Offered through One Medical primary care for eligible patients.3

### Related Stocks

- [NVO.US](https://longbridge.com/en/quote/NVO.US.md)
- [LLY.US](https://longbridge.com/en/quote/LLY.US.md)
- [XRT.US](https://longbridge.com/en/quote/XRT.US.md)
- [RTH.US](https://longbridge.com/en/quote/RTH.US.md)
- [AMZW.US](https://longbridge.com/en/quote/AMZW.US.md)
- [ELIL.US](https://longbridge.com/en/quote/ELIL.US.md)
- [AMZZ.US](https://longbridge.com/en/quote/AMZZ.US.md)
- [IBUY.US](https://longbridge.com/en/quote/IBUY.US.md)
- [EBIZ.US](https://longbridge.com/en/quote/EBIZ.US.md)
- [LLYX.US](https://longbridge.com/en/quote/LLYX.US.md)
- [AMZU.US](https://longbridge.com/en/quote/AMZU.US.md)
- [NVOX.US](https://longbridge.com/en/quote/NVOX.US.md)
- [ONLN.US](https://longbridge.com/en/quote/ONLN.US.md)
- [AMZN.US](https://longbridge.com/en/quote/AMZN.US.md)

## Related News & Research

- [Eli Lilly (LLY) Is Up 6.0% After Obesity Drug Data And $4.5B Manufacturing Push - Has The Bull Case Changed?](https://longbridge.com/en/news/286629257.md)
- [Trump purchased Eli Lilly stock as policies favored its drugs](https://longbridge.com/en/news/286791021.md)
- [Eli Lilly (LLY) Is the Face of the Obesity Boom. Has the Market Already Priced It In?](https://longbridge.com/en/news/286727957.md)
- [Key facts: Novo Nordisk early −21.6% 64w; Rexall delivery Canada](https://longbridge.com/en/news/286343869.md)
- [Eli Lilly’s New Alopecia Drug Trial Moves Forward, Expanding Its Immunology Pipeline](https://longbridge.com/en/news/286445763.md)